Randomized Comparison of Oral Valacyclovir and Intravenous Ganciclovir for Prevention of Cytomegalovirus Disease after Allogeneic Bone Marrow Transplantation-Reference-Cited by-同舟云学术

Randomized Comparison of Oral Valacyclovir and Intravenous Ganciclovir for Prevention of Cytomegalovirus Disease after Allogeneic Bone Marrow Transplantation

Published:2003-03-15 Issue:6 Volume:36 Page:749-758
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:CLIN INFECT DIS

Author:

Winston Drew J.,Yeager Andrew M.,Chandrasekar Pranatharthi H.,Snydman David R.,Petersen Finn Bo,Territo Mary C.,

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/36/6/749/907444/36-6-749.pdf

Reference30 articles.

1. Risk Factors for Cytomegalovirus Infection after Human Marrow Transplantation

2. Cytomegalovirus Infections After Allogeneic Bone Marrow Transplantation

3. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study

4. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of letermovir prophylaxis for cytomegalovirus infection after hematopoietic stem cell transplantation;Blood Science;2024-01

2. Efficacy, Safety, and Cost-effectiveness Analysis of Antiviral Agents for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation Recipients;Transplantation;2023-12-05

3. Safety and efficacy of weight‐based ganciclovir dosing strategies in overweight/obese patients;Transplant Infectious Disease;2023-08-24

4. Effectiveness of letermovir for cytomegalovirus prophylaxis in allogeneic hematopoietic stem cell transplant recipients: A global systematic review;Journal of the American Pharmacists Association;2023-07

5. Use of Letermovir for CMV Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: Review of the Literature and Single-Center Real-Life Experience;Hemato;2023-04-28